These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19473409)

  • 41. Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy.
    Fuller JR; Knockenhauer KE; Leksa NC; Peters RT; Batchelor JD
    Blood; 2021 May; 137(21):2970-2980. PubMed ID: 33569592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction.
    Batlle J; Lourés E; Vila P; Hernández MC; Méndez JA; Torea J; Rendal E; Couselo MJ; Filgueira A; López Fernández MF
    Ann Hematol; 1997 Sep; 75(3):111-5. PubMed ID: 9368480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system.
    Ogiwara K; Nogami K; Hosokawa K; Ohnishi T; Matsumoto T; Shima M
    Haemophilia; 2015 Jan; 21(1):71-80. PubMed ID: 25545301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
    Brinkhous KM; Sandberg H; Garris JB; Mattsson C; Palm M; Griggs T; Read MS
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8752-6. PubMed ID: 3936044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulated release of VWF and FVIII and the biologic implications.
    Haberichter SL; Shi Q; Montgomery RR
    Pediatr Blood Cancer; 2006 May; 46(5):547-53. PubMed ID: 16470522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of inherited von Willebrand disease in 2006.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):616-20. PubMed ID: 16977571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear condition.
    Yaoi H; Shida Y; Kitazawa T; Shima M; Nogami K
    Haemophilia; 2021 Mar; 27(2):e194-e203. PubMed ID: 33555083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro.
    Montilla M; Atienza-Navarro I; García-Cozar FJ; Castro C; Rodríguez-Martorell FJ; Ruiz FA
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization.
    Jorieux S; Gaucher C; Goudemand J; Mazurier C
    Blood; 1998 Dec; 92(12):4663-70. PubMed ID: 9845532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy.
    Nishino M; Nishino S; Sugimoto M; Shibata M; Tsuji S; Yoshioka A
    Int J Hematol; 1996 Aug; 64(2):127-34. PubMed ID: 8854570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
    Yaoi H; Shida Y; Ogiwara K; Kitazawa T; Shima M; Nogami K
    Haemophilia; 2022 Sep; 28(5):694-701. PubMed ID: 35478475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A.
    Delignat S; Repessé Y; Navarrete AM; Meslier Y; Gupta N; Christophe OD; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2012 Mar; 18(2):248-54. PubMed ID: 22044692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
    Nesbitt IM; Goodeve AC; Guilliatt AM; Makris M; Preston FE; Peake IR
    Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
    Karlman M; Holmström M; Wiman B
    Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of aerobic exercise on haemostatic indices in paediatric patients with haemophilia.
    Kumar R; Bouskill V; Schneiderman JE; Pluthero FG; Kahr WH; Craik A; Clark D; Whitney K; Zhang C; Rand ML; Carcao M
    Thromb Haemost; 2016 Jun; 115(6):1120-8. PubMed ID: 26917411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.